Glenmark Pharmaceuticals has got a favourable verdict from a
As per the information available, the US District Court of New Jersey on Monday rejected pleas by Abbott Laboratories and Sanofi-Aventis to restrain the Indian firm from launching its generic version of the drug in the
Glenmark has already got approval from the Food and Drug Administration (FDA) for launching the drug in the
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1846.95 |
Dr. Reddys Lab | 1350.65 |
Cipla | 1490.55 |
Lupin | 2357.75 |
Zydus Lifesciences | 961.75 |
View more.. |